| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.02 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |